Immune checkpoint inhibitors (ICIs)

Tumor microenvironment (TME)

Regulatory T lymphocytes (Treg)

Myeloid-derived suppressor cells (MDSCs)

Tumor-associated macrophages (TAMs)

Chemotherapies (CT)

Targeted Therapies (TT)

Tyrosine Kinase Inhibitor (TKI)

Monoclonal antibodies (mAb)

Immunogenic cell death (ICD)

High-Mobility Group Box 1 (HMGB1)

Natural Killer (NK)

Dendritic cells (DCs)

Cancer Associated Fibroblast (CAF)

Indoleamine 2,3-DiOxygenase (IDO)

Inducible Nitric Oxide Synthase (iNOS)

Arginase 1 (Arg1)

Cyclo-oxygenase (COX)

Prostaglandin E2 (PGE2)

Signal Transducer and Activator of Transcription 3 (STAT3)

Vascular Endothelial Growth Factor A (VEGF-A)

Programmed cell Death-Ligand 1 (PD-L1)

Programmed cell Death protein 1 (PD-1)

Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)

T-cell immunoglobulin and immunoreceptor Tyrosine-based inhibitory domain (TIGIT)

Non-Squamous-Non-Small Cell Lung Cancer (NS-NSCLC)

Breast Cancer (BC)

HepatoCarcinoma Cancer (HCC)

ColoRectal Cancer (CCR)

Peripheral Blood Mononuclear Cells (PBMCs)

Cytotoxic T lymphocyte (CTL)

Immunoglobulin-like transcript 4 (ILT4)

Retinoid X receptor (RXR)

Cisplatin-Pemetrexed (CP)

Optineurin (OPTN)

Janus kinase 1/2 (JAK 1/2)

Tumor-infiltrating lymphocytes (TILs)

Breast Cancer (BC)

Triple-negative breast cancer (TNBC)

Hormone-receptor breast cancer (HR+BC)

Human Epidermal Growth Factor Receptor-2 (HER-2)

Antibody-drug-conjugates (ADC)

Cyclin-dependent kinases 4 and 6 inhibitors (CDK4/6i)

Poly (ADP-ribose) polymerase (PARP)

Colony-stimulating factor 1 receptor axis (CSF1/CSF1R)

Interferon (IFN)

Antibody-dependent cell-mediated cytotoxicity (ADCC)

Temporary Use Authorization (ATU)

Phosphodiesterase type 5 (PDE5)

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)

Chemokine Receptor type 4 (CXCR4)

C-Chemokine receptor type 2 (CCR2)

Microsatellite-instable (MSI+)

Protein tyrosine phosphatase-2 (SHP2)

C-C chemokine receptor type 5 (CCR5)

Mouse Double Minute 2 (MDM2)

Yes‐associated protein 1 (YAP1)